[Exploration of the mechanisms of portal hypertension driven by metabolic disorders in non-cirrhotic stages of metabolic-associated fatty liver disease]. [PDF]
Zhao YQ, Wang Y, Liu JJ, You H, Zhao JJ.
europepmc +1 more source
[Advances in the diagnosis and treatment of portal hypertensive gastrointestinal and bile duct disease]. [PDF]
Xu JH, Yu YY, Xu XY.
europepmc +1 more source
[<i>Chaihu Shugan San</i> inhibits C3/C3aR-mediated microglial M1 polarization to improve hippocampal synaptic plasticity in mice with menopausal syndrome with liver <i>qi</i> stagnation]. [PDF]
Zhong Y +11 more
europepmc +1 more source
[Alcoholic liver disease: new insights into an undeniable challenge and strategies for prevention and treatment]. [PDF]
Tang CW.
europepmc +1 more source
[Analyzing research advances in single-cell sequencing technology for immunopathological mechanisms in acute-on-chronic liver failure]. [PDF]
Zang SX +5 more
europepmc +1 more source
[Prospects and mechanistic insights into the use of recombinant human growth hormone in the treatment of pediatric inflammatory bowel disease]. [PDF]
Zhang LD, Li J, Yu Y, Xiao Y.
europepmc +1 more source

